Health Care Utilization and Costs in the Year Prior to Arthroscopic Rotator Cuff Repair

Azeem Tariq Malik; Mathangi Sridharan; Julie Y Bishop; Safdar N Khan; Grant L Jones; Andrew S Neviaser; Gregory L Cvetanovich

doi:10.1177/2325967120937016

Health Care Utilization and Costs in the Year Prior to Arthroscopic Rotator Cuff Repair

Orthop J Sports Med. 2020 Jul 24;8(7):2325967120937016. doi: 10.1177/2325967120937016. eCollection 2020 Jul.

Authors

Azeem Tariq Malik¹, Mathangi Sridharan¹, Julie Y Bishop¹, Safdar N Khan¹, Grant L Jones¹, Andrew S Neviaser¹, Gregory L Cvetanovich¹

Affiliation

¹ Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

Abstract

Background: A majority of cost-control strategies in arthroscopic rotator cuff repair (RCR) have been concentrated on the perioperative and post-acute care periods, with the preoperative health care period being largely overlooked.

Purpose: To report the distribution of costs associated with health care utilization within the year prior to arthroscopic RCR.

Study design: Economic and decision analysis; Level of evidence, 3.

Methods: The 2007 through 2015 (third quarter) Humana Administrative Claims database was queried using Current Procedural Terminology code 29827 to identify patients undergoing arthroscopic RCR for only degenerative rotator cuff tears. The study cohort was divided into 2 distinct groups based on insurance plan: commercial or Medicare Advantage (MA). Total 1-year costs, per-patient average reimbursements (PPARs), and trends in utilization for the following preoperative health care resource categories were studied: office visits, radiographs, magnetic resonance imaging (MRI) scans, computed tomography (CT) scans, steroid injections, hyaluronic acid (HA) injections, physical therapy, and pain medications (opioids + nonopioids).

Results: A total of 18,457 MA and 6530 commercial beneficiaries undergoing arthroscopic RCR over the study period were included. Total 1-year preoperative costs (in US$) amounted to $16,923,595 ($916/patient) and $8,397,291 ($1285/patient) for MA and commercial beneficiaries, respectively. The largest proportion of total 1-year costs for both MA and commercial beneficiaries was accounted for by MRI scans (36% and 56%, respectively). PPARs for each health care resource category were as follows: office visits (MA, $240; commercial, $249), radiographs (MA, $60; commercial, $93), MRI scans (MA, $385; commercial, $813), CT scans (MA, $223; commercial, $562), steroid injections (MA, $97; commercial, $137), HA injections (MA, $422; commercial, $602), physical therapy (MA, $473; commercial, $551), and pain medications (MA, $208; commercial, $136). High health care utilization within the past 3 months before surgery was noted for radiographs, physical therapy, opioids, steroid injections, and office visits, with up to 40% to 90% of 1-year PPARs being accounted for within this time period alone.

Conclusion: Approximately $900 to $1300 per patient was spent in rotator cuff-related health care resource use in the year prior to undergoing arthroscopic RCR. As we begin to implement value in shoulder surgery, judicious use of nonoperative treatment modalities among patients who would not benefit from nonoperative care will be an effective way of reducing costs.

Keywords: health care expenses; insurance; resource utilization; rotator cuff.